Grown Rogue Total Debt vs. Current Valuation
| GRUSF Stock | USD 0.67 0.01 1.52% |
For Grown Rogue profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Grown Rogue to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Grown Rogue International utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Grown Rogue's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Grown Rogue International over time as well as its relative position and ranking within its peers.
Grown |
Grown Rogue International Current Valuation vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Grown Rogue's current stock value. Our valuation model uses many indicators to compare Grown Rogue value to that of its competitors to determine the firm's financial worth. Grown Rogue International is rated below average in total debt category among its peers. It is rated below average in current valuation category among its peers reporting about 15.39 of Current Valuation per Total Debt. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Grown Rogue's earnings, one of the primary drivers of an investment's value.Grown Total Debt vs. Competition
Grown Rogue International is rated below average in total debt category among its peers. Total debt of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 179.48 Million. Grown Rogue maintains roughly 1.37 Million in total debt contributing less than 1% to equities under Drug Manufacturers—Specialty & Generic industry.
Grown Current Valuation vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Grown Rogue |
| = | 1.37 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Grown Rogue |
| = | 21.02 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Grown Current Valuation vs Competition
Grown Rogue International is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 887.13 Million. Grown Rogue holds roughly 21.02 Million in current valuation claiming about 2.37% of equities under Drug Manufacturers—Specialty & Generic industry.
Grown Rogue Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Grown Rogue, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Grown Rogue will eventually generate negative long term returns. The profitability progress is the general direction of Grown Rogue's change in net profit over the period of time. It can combine multiple indicators of Grown Rogue, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Grown Rogue International Inc., through its subsidiaries, engages in growing and selling cannabis products in the United States. Grown Rogue International Inc. is headquartered in Medford, Oregon. Grown Rogue operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Grown Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Grown Rogue. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Grown Rogue position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Grown Rogue's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Grown Rogue without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Use Investing Themes to Complement your Grown Rogue position
In addition to having Grown Rogue in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Single Stock ETFs Thematic Idea Now
Single Stock ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Single Stock ETFs theme has 99 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Single Stock ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Grown OTC Stock
To fully project Grown Rogue's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Grown Rogue International at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Grown Rogue's income statement, its balance sheet, and the statement of cash flows.